Primary Record
ent-Emtricitabine
- In stock
- 6,665 g
- Purity
- 99.4 %
- CAS
- 137530-41-7
Compound Identifiers & Properties
- CAS
- 137530-41-7
- PubChem CID
- 454858
- SMILES
- C1[C@@H](O[C@@H](S1)CO)N2C=C(C(=NC2=O)N)F
- Canonical SMILES
- Nc1nc(=O)n([C@H]2CS[C@@H](CO)O2)cc1F
Names & Synonyms
- ent-Emtricitabine
- Oxathiolan
- Racivir
- Emtricitabine
- 137530-41-7
- (+)-EMTRICITABINE
- Emtricitabine Enantiomer
- Emtricitabine, (+)-
- 5FC-(+)-beta
- Racivir (TM)
- (+)-FTC
- 5-FSddC
- AC1L9RWY
- (2S,5R)-Emtricitabine
- UNII-9PDN1V466A
- RefChem:1048894
- 9PDN1V466A
- C8H10FN3O3S
- CHEMBL89554
- SCHEMBL267686
- DTXSID701288260
- ZINC5472
- CTK4C0856
- Emtricitabine Enantiomer Impurity
- DLS-022
- XQSPYNMVSIKCOC-RITPCOANSA-N
- 2-EPI-(-)-EMTRICITABINE
- DTXCID601718903
- 5FC-(+).b.
- PSI 5004
- (+/-)-FTC
- CID454858
- MFCD00870152
- (+)-2'-Deoxy-3'-thia-5-fluorocytidine
- (+)-2'-deoxy-5-flouro-3'-thiacytidine
- AKOS027256113
- BW-524W-91
- NE16704
- EMRICITABINE IMPURITY D [WHO-IP]
- EMTRICITABINE ENANTIOMER [WHO-IP]
- SC-89862
- ( )-2'-deoxy-5-flouro-3'-thiacytidine
- 2',3'-Dideoxy-5-fluoro-3'-thiacytidine
- J496.065C
- FT-0601789
- FT-0667848
- FT-0667849
- 4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
- W12863
- (+)-2a(2)-Deoxy-3a(2)-thia-5-fluorocytidine
- 4-Amino-5-fluoro-1-((2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
- A852366
- Q7279762
- 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-
- 4-Amino-5-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one
- 4-Amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
- (+)-(2S,5R)-5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
- 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-((2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-
- (+)-(2S,5R)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
- 143491-54-7
- 4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2-dihydropyrimidin-2-one
- (+)-2 inverted exclamation mark -Deoxy-3 inverted exclamation mark -thia-5-fluorocytidine
- (2S-cis)-4-Amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
- 1-[(2S,5R)-2alpha-Hydroxymethyl-1,3-oxathiolan-5alpha-yl]-5-fluorocytosine
- 4-Amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl ]-2(1H)-pyrimidinone
- 4-Amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
- (2S)-5alpha-(2-Oxo-4-amino-5-fluoro-1,2-dihydropyrimidine-1-yl)-1-oxa-3-thiacyclopentane-2alpha-methanol
- 1-[(2S)-2alpha-(Hydroxymethyl)-1,3-oxathiolane-5alpha-yl]-4-amino-5-fluoro-1,2-dihydropyrimidine-2-one
- 143491-57-0
- 145416-34-8
- 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, rel- (+/-)-cis-1-(2-Hydroxymethyl)-1,3-oxathiolan-5-yl)-5-fluorocytosine
- 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-; 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)-; 1,3-Oxathiolane, 2(1H)-pyrimidinone deriv.; 4-Amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone; (+)-2'-Deoxy-3'-thia-5-fluorocytidine; (+)-FTC; (2'S,5'R)-Emtricitabine; 4-Amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
- 4-AMINO-5-FLUORO-1-((2S,5R)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)PYRIMIDIN-2(1H)-ONE [WHO-IP]
- FTC
- RCV